These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4337228)

  • 21. [Hypophosphatemic vitamino-resistant rickets. Study of 6 cases].
    Fontaine G; Farriaux JP; Chellé JC
    Pediatrie; 1970; 25(1):43-71. PubMed ID: 5416720
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum parathyroid hormone in X-linked hypophosphatemia.
    Arnaud C; Glorieux F; Scriver C
    Science; 1971 Aug; 173(3999):845-7. PubMed ID: 5315247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of normocalcemic primary hyperparathyroidism with osteomalacia.
    Shimada I; Inaba M; Nakano H; Miki T; Nishizawa Y; Morii H
    Endocrinol Jpn; 1986 Oct; 33(5):575-82. PubMed ID: 3830067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D-resistant rickets and 25-hydroxycholecalciferol.
    Manis J; Norman A
    Br Med J; 1975 May; 2(5969):478-9. PubMed ID: 167901
    [No Abstract]   [Full Text] [Related]  

  • 25. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
    Tsujimura T; Sakaguchi K; Aozasa K
    Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
    Firth RG; Grant CS; Riggs BL
    Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case.
    Yun KI; Kim DH; Pyo SW
    J Oral Maxillofac Surg; 2009 Feb; 67(2):402-5. PubMed ID: 19138617
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
    Heylen A; Dasnoy D; Hustin J; Pochet JM
    Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum 25-hydroxyvitamin D in infantile rickets.
    Arnaud SB; Stickler GB; Haworth JC
    Pediatrics; 1976 Feb; 57(2):221-5. PubMed ID: 175345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone secretion in familial vitamin-D-resistant rickets.
    Reitz RE; Weinstein RL
    N Engl J Med; 1973 Nov; 289(18):941-5. PubMed ID: 4355232
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
    Cohanim M; DeLuca HF; Yendt ER
    Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
    Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)].
    Schabel F; Kurz R; Madreiter H; Reinken L; Zieglauer H
    Padiatr Padol; 1977; 12(2):152-7. PubMed ID: 193082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATYPICAL VITAMIN-D RESISTANT OSTEOMALACIA. REPORT OF A CASE.
    YOSHIKAWA S; KAWABATA M; HATSUYAMA Y; HOSOKAWA O; FUJITA T
    J Bone Joint Surg Am; 1964 Jul; 46():998-1007. PubMed ID: 14192510
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vitamin-resistant rickets cured by removal of a bone tumor. Review of the literature].
    François S; Lefort G; Poli-Merol ML; Gaillard D; Roussel B; Sulmont V; Daoud S
    Rev Chir Orthop Reparatrice Appar Mot; 1997; 83(4):387-92. PubMed ID: 9452815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL; Feig DS; Blackstein ME
    J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary parathyroid gland hyperplasia in dogs: six cases (1982-1991).
    DeVries SE; Feldman EC; Nelson RW; Kennedy PC
    J Am Vet Med Assoc; 1993 Apr; 202(7):1132-6. PubMed ID: 8473230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sporadic adult hypophosphatemic vitamin D resistant osteomalacia (phosphate diabetes) and hyperparathyroidism].
    Kistler HJ; Bonetti A; Frey P; Fischer JA
    Schweiz Med Wochenschr; 1976 Dec; 106(51):1855-62. PubMed ID: 1013714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets.
    Jung GH; Kim JD; Cho Y; Chung SH; Lee JH; Sohn KR
    J Pediatr Orthop B; 2010 Jan; 19(1):127-32. PubMed ID: 19801953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.